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Abstract of thesis 
 
Methods: Her key technology includes the murine atherosclerosis imaging system targets the transgenic macrophages 
expressing Near Infrared Fluorescent Protein (iRFP- excitation 690 nm / emission 713 nm) in the atheroma, which 
has not been published before in atherosclerosis imaging. LDL receptor-deficient mice, LDLR-/- is a well used 
hypercholesterolemic model for atherosclerosis by feeding high cholesterol diet (HCD).   LDLR-/- were 
reconstituted with bone marrow cells from beta-actin promoter derived iRFP transgenic mice (iRFP→LDLR-/-) so 
that monocytes or macrophages in atherosclerotic region would be labeled with iRFP and used throughout the 
experiment. iRFP→LDLR-/- mice fed a normal diet (ND) and LDLR-/- mice transplanted with wild-type (WT) BM 
cells were used as controls. Atherosclerosis was induced by special non-fluorescent HCD. Atherosclerosis was 
compared among the three differently induced mouse groups; only ND fed ND group, ND and HCD alternatively fed 
HCD/ND group, and only HCD group. The live in vivo imaging system IVIS was used as the imaging device. All the 
IVIS images were acquired with excitation/emission wavelengths of 625/720 nm and 710/760 nm and with an 
exposure time of 1 second. In vivo, ex vivo IVIS® imaging were carried out every 2 weeks to visualize the plaque 
progression. Oil Red O staining, immuno-histochemical analysis and FACS analysis were employed for conformation. 
After 8 weeks, differently HCD fed three mice groups were imaged for atherosclerotic lesions. Then, the mice were 
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 sacrificed, and ex vivo imaging of the aortas was performed, followed by ORO staining. ORO staining of the aortas 
and aortic valves showed that the different HCD feeding patterns induced different extents of atherosclerosis in each 
group, and the observed in vivo iRFP signal areas demonstrated a signal distribution corresponding to the actual 
plaque-positive areas. Notably, a significant correlation was observed between the iRFP in vivo signal area and the 
ex vivo ORO-positive plaque area of the aortas. It was suggested that  iRFP-based imaging system can be used to 
visualize macrophage-rich plaque burden in vivo.  
IVIS images were acquired every two weeks to observe the thoracic signal in the three mice groups.  From the 
fourth week of induction, thoracic signals were observed in the HCD/ND and HCD groups. The thoracic iRFP signal 
progression was clearly observed in the same mice at week 6 and week 8 after induction. Overall, these results 
indicate that established imaging system could clearly capture the time course of disease progression in individual 
mice in a relatively straightforward fashion. This system also allows differences in plaque burden to be quantified 
among mice in the same group. 
Conclusion: Established iRFP incorporated new murine atherosclerosis imaging system is able to noninvasively 
image atheroma positive areas in thoracic aorta and to generate longitudinal data of thoracic atherosclerosis lesion 
progression, validating the ability of the system to be effectively used in atherosclerosis disease progression and drug 
development studies. 
 
 
 Abstract of assessment result 
 
【Review】 
This iRFP incorporated new murine atherosclerosis imaging system she established is a novel and fantastic 
technology to visualize atherosclerosis.  Atherosclerosis has been studied using many murine models for decades, 
but analytical procedure was so troublesome and difficult. This astonishing cutting edge methodology will be a 
tremendous help for atherosclerosis researchers. It can be expandable to clinics and potentially other infiltrative 
disorders.  The project consists of establishment of in vitro methodology especially about strength and 
quantitativeness of the iRFP signal and in vivo application to atherosclerosis experiments.  The study was carefully 
organized, well done step by step, obtained the beautiful linearity, feasibility and effectiveness, deserving a mile 
stone-class of atherosclerosis research.  Usage of macrophage specific promoter for iRFP gene or photoacoustic 
system was discussed as future experiments, and she very well responded to questions.   The signal from 
macrophage in the entire atherosclerotic lesion might limit significance of information whereas it might help 
understanding of new aspects such as apoptosis, efferocytosis, or xanthoma. 
 
【Result】 
The final examination committee conducted a meeting as a final examination on 23 01, 2019. The applicant 
provided an overview of dissertation, addressed questions and comments raised during Q&A session. All of the 
committee members reached a final decision that the applicant has passed the final examination. 
 
【Conclusion】 
Therefore, the final examination committee approved that the applicant is qualified to be awarded a Doctor of 
Philosophy in Human Biology. 
